Trending Topics

 
 
  • Cardiac Critical Care: Limiting Unnecessary Treatment   Dr Sunil Mankad interviews Dr Gregory Barsness about Choosing Wisely when it comes to treating cardiac patients in the intensive care unit.
  • Making Decisions With, Not for, Patients   Selma Mohammed and Victor Montori explore the merits of shared decision making and highlight a tool to facilitate the discussion on whether to take a statin for primary prevention.
  • 3D Printing in Cardiovascular Medicine   Printing a functional beating heart may be a ways off, but 3D printed models of hearts, valves, and other anatomy are currently used to plan surgical and interventional procedures.
  • Coronary Calcium Score: Basics and Beyond   Everything you need to know about CAC testing for CV risk assessment: who, when, and what it means.
  • Early Menopause: Precursor to Coronary Heart Disease?   Drs Scott Wright and Sharon Mulvagh discuss cardiovascular health in postmenopausal women: risk, hormones, and prevention.
  • Motivating Patients to Move   If poor fitness and sedentary lifestyles are diseases, what is the cure? Drs Widmer and Allison discuss strategies to increase patient levels of physical activity.
  • Atenolol vs Losartan in Patients With Marfan Syndrome Drs Bowen and Connolly discuss the results of a landmark head-to-head comparison of losartan vs atenolol in patients with Marfan syndrome.
  • Brugada Syndrome vs Pattern: What You Should Know   A review on how to distinguish Brugada syndrome from Brugada pattern, and when to intervene in at-risk patients.
  • Cardiology Conundrum: Aspirin for Primary Prevention   A recent FDA alert adds to the uncertainty about aspirin in primary prevention. Drs Mulvagh and Lopez-Jimenez sort it out.
  • PCI and ACS: Where Do Vorapaxar and Bivalirudin Fit In?   Drs. Pereira and Sandhu discuss contemporary therapy now that vorapaxar is approved.
  • Ebstein's Anomaly   Drs Rihal and Dearani discuss this complex heart problem, which can show up anytime from the newborn period to old age.
  • TAVR Update Post ACC 2014 With Dr Holmes   Dr Nkomo interviews Dr David Holmes on the TVT registry and CHOICE trial data from the ACC.
  • Any Hope for Renal Denervation After SYMPLICITY HTN-3?   Drs. Brady and Gulati discuss whether the operators achieved correct renal denervation in the sham-controlled SYMPLICITY HTN-3 trial.
  • Marfan Syndrome: New Challenges   Many individuals with Marfan syndrome remain undiagnosed, and in spite of a much-improved chance of a normal lifespan, the risk of sudden death remains for untreated individuals.
  • WPW Syndrome: Symptom-Free Is Not Risk Free   Drs Gersh and Cannon discuss how to evaluate and when to intervene in WPW syndrome.
  • Lessons From 500 Heart Transplants   Drs Rihal, Edwards, and Kushwaha review when a ventricular assist device or transplant should be considered as Mayo celebrates its 500th heart transplant.
  • Repair or Replacement in Ischemic Mitral Regurgitation?   Dr Jay Widmer and Dr Rakesh Suri discuss the practical take-aways from a recent study comparing valve repair with valve replacement in patients with severe ischemic MR.
  • Spontaneous Coronary Artery Dissection: Don't Miss It   Drs Simari and Gulati review SCAD; a condition that may be more common than previously suspected and one where PCI may do more harm than good.
  • Cardiology and the Pilot: Fit to Fly?   Dr. Rihal interviews aerospace medicine specialist Dr. Cowl on the cardiologist's role when the patient is a professional pilot.
  • Exercise and Depression in Cardiac Patients Drs Gersh and Thomas discuss the UPBEAT study and other data on exercise and depression in patients with CAD.